Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note published on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

CALA opened at $0.00 on Tuesday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.